The century-long pilgrimage of bradykinin B2 receptor antagonists
Pruneau, D.; Bellamy, F.D.
Idrugs the Investigational Drugs Journal 3(6): 563-566
2000
ISSN/ISBN: 1369-7056 PMID: 16096902 Document Number: 513490
Document emailed within 1 workday
Related Documents
Liebmann, C.; Bossé, R.; Escher, E. 1994: Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue Molecular Pharmacology 46(5): 949-956Stewart, J.M. 1994: The present and future of bradykinin antagonists Brazilian Journal of Medical and Biological Research 27(8): 1699-1706
Ribet, A.; Balas, D.; Bastie, M.J.; Senegas-Balas, F.; Escourrou, J.; Bommelaer, G.; Pradayrol, L. 1981: Long term effects of H2-receptor antagonists (cimetidine and ranitidine) on the human gastric and duodenal mucosa Scandinavian Journal of Gastroenterology. Suppl 70: 155-174
Yndgaard, S.; Lippert, F.K.; Berthelsen, P.G. 1998: Do cardioselective beta-antagonists block the cardiac beta-receptor function also in the long run? Ugeskrift for Laeger 160(18): 2706-2709
Bank, S.; Marks, I.N.; Louw, J.H. 1980: The long-term effects of vagotomy and drainage, parietal cell vagotomy and H2 receptor antagonists on duodenal ulcers and gastric function and structure South African Medical Journal 57(16): 622-627
Roscher, A.A.; Klier, C.; Dengler, R.; Faussner, A.; Müller-Esterl, W. 1990: Regulation of bradykinin action at the receptor level Journal of Cardiovascular Pharmacology 15(Suppl 6): S39-S43
Nielsen, S.T.; Dove, P.A.; Strike, D.P.; Schiehser, G.A. 1987: Structural modification of H2-receptor antagonists provide post-H2-receptor gastric antisecretory activity Drugs under Experimental and Clinical Research 13(5): 297-304
Daniels, A.J.; Matthews, J.E.; Viveros, O.H.; Leban, J.J.; Cory, M.; Heyer, D. 1995: Structure-activity relationship of novel pentapeptide neuropeptide y receptor antagonists is consistent with a noncontinuous epitope for ligand-receptor binding Molecular Pharmacology 48(3): 425-432
Desai, M.A.; Burnett, J.P.; Ornstein, P.L.; Schoepp, D.D. 1995: Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists Journal of Pharmacology and Experimental Therapeutics 272(1): 38-43
Wilson, D.D.; de Garavilla, L.; Kuhn, W.; Togo, J.; Burch, R.M.; Steranka, L.R. 1989: D-Arg-[Hyp3-D-Phe7]-bradykinin, a bradykinin antagonist, reduces mortality in a rat model of endotoxic shock Circulatory Shock 27(2): 93-101
Suzuki, N.; Matsunaga, T.; Kanaho, Y.; Nozawa, Y. 1993: The mechanism of bradykinin-induced arachidonic acid release in osteoblast-like MC3T3-E1 cells phospholipase A2 activation by bradykinin and its regulation by protein kinase C and calcium Nihon Seikeigeka Gakkai Zasshi 67(10): 935-943
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Saller, C.F.; Czupryna, M.J.; Salama, A.I. 1990: 5-HT2 receptor blockade by ICi 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade Journal of Pharmacology and Experimental Therapeutics 253(3): 1162-1170
Pellas, T.C.; Wennogle, L.P. 1999: C5a receptor antagonists Current Pharmaceutical Design 5(10): 737-755
Moss, J.; Hom, B.E.; Hewlett, E.L.; Tsai, S.C.; Adamik, R.; Halpern, J.L.; Price, S.R.; Manganiello, V.C. 1988: Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation Molecular Pharmacology 34(3): 279-285
Mazure, P.A. 1996: Gastric acid secretion inhibitors: H2 receptor antagonists (H2RA), proton pump inhibitors (PPI) or acid pump antagonists (APA) Acta Gastroenterologica Latinoamericana 26(4): 263-265
Audet, R.; Rioux, F.; Drapeau, G.; Marceau, F. 1997: Cardiovascular effects of Sar-[D-Phe8]des-Arg9-bradykinin, a metabolically protected agonist of B1 receptor for kinins, in the anesthetized rabbit pretreated with a sublethal dose of bacterial lipopolysaccharide Journal of Pharmacology and Experimental Therapeutics 280(1): 6-15
Wolsing, D.H.; Rosenbaum, J.S. 1993: The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways Journal of Pharmacology and Experimental Therapeutics 266(1): 253-261
Spitz, I.M. 2006: Progesterone receptor antagonists Current Opinion in Investigational Drugs 7(10): 882-890
Chung, O.; Unger, T. 1996: Angiotensin Ii receptor antagonists Der Internist 37(5): 534-538; Discussion 538